NCT00092105View on ClinicalTrials.gov

Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 1, 2002

Primary Completion Date

January 1, 2003

Study Completion Date

January 28, 2003

Conditions
Asthma, BronchialRhinitis, Allergic, Perennial
Interventions
DRUG

MK0476, montelukast sodium

DRUG

Comparator: placebo

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00092105 - Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) | Biotech Hunter | Biotech Hunter